The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan

Table 1 Socio-demographic, clinical and laboratory data of the study participants

Variables	n	(%)
Age group (year)
< 50	132	13.2
50–69	692	69.0
≥ 70	179	17.8
Gender
Male	480	47.9
Female	523	52.1
Marital status
Single/divorced and widowed	128	12.8
Married	875	87.2
Working status
Unemployed	344	34.3
Employed	280	27.9
Retired	379	37.8
Physical activity
Regular	92	9.2
Not regular	288	28.7
No physical activity	623	62.1
Family history of diabetes	869	86.6
Regular visit to treating physician	917	91.4
Body mass index (BMI) (kg/m²)^a
Normal	85	8.5
Over weight	302	30.1
Obese	616	61.4
Duration of diabetes (year)
< 5	333	33.2
5–11	356	35.5
≥ 12	314	31.3
Hypertension	860	85.7
Dyslipidemia	886	88.3
Retinopathy	196	19.5
Nephropathy	94	9.4
Cardiovascular disease	383	38.2
Type of treatment
Insulin only	128	12.8
Oral hypoglycemia agents only	527	52.5
Oral hypoglycemia agents and insulin	348	34.7
Statin therapy	886	88.3
HbA1C (%)
Controlled < 7%	422	42.1
Uncontrolled ≥ 7%	581	57.9

ISSN: 1758-5996